-
1
المؤلفون: Ayumi Tokunaga, Shingo Fujita, Yoshiya Hosokawa, Yukari Fujita, Kenji Fukui, Takekazu Kimura, Iichiro Shimomura, Tomomi Horii, Junji Kozawa
المصدر: Obesity Science & Practice
Obesity Science & Practice, Vol 7, Iss 3, Pp 346-352 (2021)مصطلحات موضوعية: 0301 basic medicine, medicine.medical_specialty, Short Communication, Endocrinology, Diabetes and Metabolism, 030209 endocrinology & metabolism, Type 2 diabetes, Gastroenterology, 03 medical and health sciences, 0302 clinical medicine, Fat accumulation, Internal medicine, Hounsfield scale, medicine, In patient, terms: type 2 diabetes, 030109 nutrition & dietetics, Nutrition and Dietetics, business.industry, pancreatic fat, Fatty liver, Retrospective cohort study, medicine.disease, RC31-1245, medicine.anatomical_structure, Sodium/Glucose Cotransporter 2, Pancreas, business, SGLT‐2 inhibitor
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::035f1ebdcd2b6f172c58c6ff1e10cd33Test
https://doi.org/10.1002/osp4.482Test -
2
المؤلفون: Paresh Dandona, Depict Investigators, Depict, Niki Arya, Simon Heller, Paolo Di Bartolo, Lars Hansen, Richard M. Bergenstal, Eiichi Araki, Moshe Phillip, John Xu, Markus F. Scheerer, Nayyar Iqbal, Chantal Mathieu, Marcus Lind, Fredrik Thoren
المصدر: Diabetes, Obesity & Metabolism
مصطلحات موضوعية: Adult, medicine.medical_specialty, Diabetic ketoacidosis, Endocrinology, Diabetes and Metabolism, 030209 endocrinology & metabolism, 030204 cardiovascular system & hematology, Body weight, Placebo, 03 medical and health sciences, chemistry.chemical_compound, dapagliflozin, DEPICT, DKA, insulin adjunct, long‐term data, severe hypoglycaemia, SGLT‐2 inhibitor, T1D, 0302 clinical medicine, Endocrinology, Double-Blind Method, Glucosides, Internal medicine, Internal Medicine, medicine, Humans, Hypoglycemic Agents, In patient, Benzhydryl Compounds, Dapagliflozin, Glycated Hemoglobin, Type 1 diabetes, business.industry, Original Articles, medicine.disease, Diabetes Mellitus, Type 1, Treatment Outcome, Pooled analysis, chemistry, Baseline characteristics, Drug Therapy, Combination, Original Article, business
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7eeabb346397e1e4e7778837ac220da0Test
https://doi.org/10.1111/dom.14248Test -
3
المصدر: Clinical Practice and Cases in Emergency Medicine
Clinical Practice and Cases in Emergency Medicine, Vol 4, Iss 3 (2020)مصطلحات موضوعية: medicine.medical_specialty, endocrine system diseases, Diabetic ketoacidosis, Case Report, 030209 endocrinology & metabolism, 030204 cardiovascular system & hematology, Emergency Nursing, Gastroenterology, 03 medical and health sciences, Pericarditis, 0302 clinical medicine, Internal medicine, Diabetes mellitus, medicine, SGLT-2 Inhibitor, business.industry, lcsh:Medical emergencies. Critical care. Intensive care. First aid, lcsh:RC86-88.9, Fasting, Emergency department, medicine.disease, Euglycemic DKA, Serum glucose, Sodium/Glucose Cotransporter 2, Emergency Medicine, business, Complication, Decreased Oral Intake
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::96f87d88c540062c01ad739f9c246461Test
https://doi.org/10.5811/cpcem.2020.4.46056Test -
4
المؤلفون: David M. Williams, Marc Evans, Asif Nawaz
المصدر: Diabetes Therapy
مصطلحات موضوعية: Drug, medicine.medical_specialty, Endocrinology, Diabetes and Metabolism, medicine.medical_treatment, media_common.quotation_subject, Renal function, 030209 endocrinology & metabolism, Type 2 diabetes, Review, 030204 cardiovascular system & hematology, End stage renal disease, CVOT, 03 medical and health sciences, End-stage renal disease, 0302 clinical medicine, Diabetes mellitus, Internal Medicine, medicine, Albuminuria, DPP-4 inhibitor, Renal replacement therapy, Diabetic kidney disease, Intensive care medicine, media_common, GLP-1 analogue, business.industry, medicine.disease, SGLT-2 inhibitor, medicine.symptom, business, Kidney disease
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b891ee9b52ffd876d0826aa5313436caTest
http://europepmc.org/articles/PMC6995804Test -
5
المصدر: Diabetes, Obesity & Metabolism
مصطلحات موضوعية: Male, medicine.medical_specialty, Endocrinology, Diabetes and Metabolism, Eligibility Determination, 030209 endocrinology & metabolism, Type 2 diabetes, 030204 cardiovascular system & hematology, 03 medical and health sciences, 0302 clinical medicine, Endocrinology, cardiovascular disease, Internal medicine, Diabetes mellitus, Prevalence, Internal Medicine, Humans, Hypoglycemic Agents, Medicine, Generalizability theory, In patient, Registries, Sodium-Glucose Transporter 2 Inhibitors, Aged, business.industry, Atherosclerotic cardiovascular disease, Brief Report, Patient Selection, Middle Aged, Atherosclerosis, medicine.disease, Diabetes Mellitus, Type 2, Cardiovascular Diseases, Brief Reports, observational study, Female, Observational study, type 2 diabetes, Trial Eligibility Criteria, business, Cardiovascular outcomes, SGLT‐2 inhibitor, Diabetic Angiopathies
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::84b6d2e74ecc41dce2827e62b8029f5dTest
https://doi.org/10.1111/dom.13738Test -
6
المصدر: Journal of Pancreatic Cancer, Vol 4, Iss 1, Pp 95-99 (2018)
Journal of Pancreatic Cancerمصطلحات موضوعية: euglycemic DKA, medicine.medical_specialty, Side effect, Diabetic ketoacidosis, medicine.medical_treatment, pancreatic cancer, Urology, Case Report, 030209 endocrinology & metabolism, lcsh:RC254-282, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Pancreatic cancer, Medicine, distal pancreatectomy, 030212 general & internal medicine, Dapagliflozin, canagliflozin, Canagliflozin, business.industry, dapagliflozin, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, medicine.disease, Pancreaticoduodenectomy, chemistry, SGLT-2 inhibitor, Pancreatectomy, pancreaticoduodenectomy, business, Cotransporter, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::58e3144adac6e3f69dedd068622517deTest
https://doi.org/10.1089/pancan.2018.0016Test -
7
المؤلفون: Julio Rosenstock, Odd Erik Johansen, Silvio E. Inzucchi, Nikolaus Marx, Darren K. McGuire, Jyothis T. George
المصدر: Journal of Pharmaceutical Policy and Practice
Journal of Pharmaceutical Policy and Practice, Vol 14, Iss 1, Pp 1-3 (2021)
Journal of pharmaceutical policy and practice 14(1), 35 (2021). doi:10.1186/s40545-020-00295-3مصطلحات موضوعية: medicine.medical_specialty, Epidemiology, 030209 endocrinology & metabolism, Context (language use), Pharmacy, Type 2 diabetes, RM1-950, 030204 cardiovascular system & hematology, Medication, Nephropathy, 03 medical and health sciences, Cardiovascular outcome trials, 0302 clinical medicine, Pharmacy and materia medica, Bias, Diabetes mellitus, medicine, Risk factor, Intensive care medicine, Risk management, Glycemic, business.industry, Health Policy, medicine.disease, RS1-441, SGLT-2 inhibitor, Commentary, Risk reduction, Therapeutics. Pharmacology, business
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cd04fa8aebb8610ac067b0fcac6d142eTest
-
8
المؤلفون: Oliver Schnell, Pieter Gillard, Per-Henrik Groop
المساهمون: Pathology/molecular and cellular medicine, Diabetes Pathology & Therapy, Diabetes Clinic, HUS Abdominal Center, Research Programs Unit, Department of Medicine, Per Henrik Groop / Principal Investigator, Clinicum, Nefrologian yksikkö, University of Helsinki, Helsinki University Hospital Area, CAMM - Research Program for Clinical and Molecular Metabolism
مصطلحات موضوعية: CHRONIC KIDNEY-DISEASE, Male, Diabetes Mellitus, Type 2/drug therapy, endocrine system diseases, medicine.medical_treatment, Endocrinology, Diabetes and Metabolism, DOUBLE-BLIND, 0302 clinical medicine, Endocrinology, Insulin, SGLT inhibition, Diabetic Nephropathies, 030212 general & internal medicine, Body mass index, METABOLIC SYNDROME, RISK, COMPLICATIONS, Diabetes, STAGE RENAL-DISEASE, GLOMERULAR HYPERFILTRATION, General Medicine, Kidney disease, Nephrology, Insulin/therapeutic use, Female, medicine.medical_specialty, Renal effects, Diabetes Mellitus, Type 1/drug therapy, Type 1 diabetes mellitus, Renal function, 030209 endocrinology & metabolism, Hypoglycemic Agents/therapeutic use, URIC-ACID, 03 medical and health sciences, Diabetes mellitus, Internal medicine, BASE-LINE CHARACTERISTICS, Internal Medicine, medicine, Hypoglycemic Agents, Humans, COTRANSPORTER 2 INHIBITORS, Diabetic kidney disease, Renal Insufficiency, Chronic, Sodium-Glucose Transporter 2 Inhibitors, Type 1 diabetes, Renal Insufficiency, Chronic/drug therapy, business.industry, Sodium-Glucose Transporter 2 Inhibitors/therapeutic use, Type 2 Diabetes Mellitus, nutritional and metabolic diseases, medicine.disease, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, 3121 General medicine, internal medicine and other clinical medicine, SGLT-2 inhibitor, Adjunctive treatment, Diabetic Nephropathies/drug therapy, Metabolic syndrome, business
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::03aec7f8c17f21dae029eac6142bfa4cTest
https://biblio.vub.ac.be/vubir/the-nephrological-perspective-on-sglt2-inhibitors-in-type-1-diabetesTest(a44fea01-9080-41df-b6e2-d8cafdc8e82c).html -
9
المؤلفون: Jaime E.M. Wong-Cruz, Miguel Brito-Sanfiel, Manuel Gargallo-Fernández, Alba Galdón Sanz-Pastor, Teresa Antón-Bravo, Juan J. Gorgojo-Martinez
المصدر: Journal of Clinical Medicine
Volume 9
Issue 7
Journal of Clinical Medicine, Vol 9, Iss 2275, p 2275 (2020)مصطلحات موضوعية: medicine.medical_specialty, endocrine system diseases, lcsh:Medicine, 030209 endocrinology & metabolism, Type 2 diabetes, 030204 cardiovascular system & hematology, Article, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, medicine, In patient, Adverse effect, canagliflozin, Canagliflozin, business.industry, lcsh:R, Type 2 Diabetes Mellitus, nutritional and metabolic diseases, Retrospective cohort study, General Medicine, medicine.disease, switch, Blood pressure, Cohort, SGLT-2 inhibitor, type 2 diabetes, business, medicine.drug
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d33705a2fe17cf8fa45f984b16ced3c4Test
-
10
المؤلفون: Kyungdo Han, Mikhail Kosiborod, Peter Fenici, You-Seon Nam, Hiddo J.L. Heerspink, Hyuk-Sang Kwon, Eric Wittbrodt, Soon Jib Yoo, Eun Sil Koh
المساهمون: Real World Studies in PharmacoEpidemiology, -Genetics, -Economics and -Therapy (PEGET), Groningen Kidney Center (GKC)
المصدر: Diabetes, Obesity & Metabolism
Diabetes obesity & metabolism, 1-12. Wiley
ISSUE=2;STARTPAGE=1;ENDPAGE=12;ISSN=1462-8902;TITLE=Diabetes obesity & metabolismمصطلحات موضوعية: Endocrinology, Diabetes and Metabolism, PROGRESSION, Type 2 diabetes, 030204 cardiovascular system & hematology, SGLT2 INHIBITORS, 0302 clinical medicine, Endocrinology, all‐, Medicine, FAILURE, Proteinuria, Symporters, Hazard ratio, EMPAGLIFLOZIN, Middle Aged, Pharmaceutical Preparations, Cardiovascular Diseases, Cohort, Original Article, medicine.symptom, SGLT‐2 inhibitor, medicine.medical_specialty, DAPAGLIFLOZIN, Renal function, 030209 endocrinology & metabolism, Lower risk, MECHANISMS, 03 medical and health sciences, Internal medicine, Diabetes mellitus, Republic of Korea, Internal Medicine, Humans, COTRANSPORTER 2 INHIBITORS, ESRD, Sodium-Glucose Transporter 2 Inhibitors, cause death, 2 inhibitor, Aged, all‐cause death, business.industry, Sodium, DIABETES-MELLITUS, KIDNEY-DISEASE, Original Articles, medicine.disease, SGLT‐, Glucose, Diabetes Mellitus, Type 2, business, Kidney disease
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a05c9d39066cebee91a2de8a5c0d61d4Test
https://pubmed.ncbi.nlm.nih.gov/33118320Test
